MRNA vs. XLV
Compare and contrast key facts about Moderna, Inc. (MRNA) and Health Care Select Sector SPDR Fund (XLV).
XLV is a passively managed fund by State Street that tracks the performance of the Health Care Select Sector. It was launched on Dec 16, 1998.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: MRNA or XLV.
Key characteristics
| MRNA | XLV | |
|---|---|---|
| YTD Return | 33.41% | 7.46% |
| 1Y Return | 5.66% | 13.29% |
| 3Y Return (Ann) | -6.14% | 7.50% |
| 5Y Return (Ann) | 41.96% | 12.50% |
| Sharpe Ratio | 0.12 | 1.27 |
| Daily Std Dev | 51.73% | 10.57% |
| Max Drawdown | -85.65% | -39.18% |
| Current Drawdown | -72.61% | -1.15% |
Correlation
The correlation between MRNA and XLV is 0.31, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
MRNA vs. XLV - Performance Comparison
In the year-to-date period, MRNA achieves a 33.41% return, which is significantly higher than XLV's 7.46% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
MRNA vs. XLV - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Moderna, Inc. (MRNA) and Health Care Select Sector SPDR Fund (XLV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
MRNA vs. XLV - Dividend Comparison
MRNA has not paid dividends to shareholders, while XLV's dividend yield for the trailing twelve months is around 1.51%.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
MRNA Moderna, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
XLV Health Care Select Sector SPDR Fund | 1.51% | 1.59% | 1.47% | 1.33% | 1.49% | 2.16% | 1.56% | 1.46% | 1.59% | 1.43% | 1.34% | 1.51% |
Drawdowns
MRNA vs. XLV - Drawdown Comparison
The maximum MRNA drawdown since its inception was -85.65%, which is greater than XLV's maximum drawdown of -39.18%. Use the drawdown chart below to compare losses from any high point for MRNA and XLV. For additional features, visit the drawdowns tool.
Volatility
MRNA vs. XLV - Volatility Comparison
Moderna, Inc. (MRNA) has a higher volatility of 16.03% compared to Health Care Select Sector SPDR Fund (XLV) at 2.40%. This indicates that MRNA's price experiences larger fluctuations and is considered to be riskier than XLV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.